The role of dysregulated ghrelin/LEAP-2 balance in anorexia nervosa. - Université de Lille Accéder directement au contenu
Article Dans Une Revue iScience Année : 2023

The role of dysregulated ghrelin/LEAP-2 balance in anorexia nervosa.


LEAP-2 is a ghrelin antagonist with an anorexigenic drive. This study investigates the evolution of plasma ghrelin and LEAP-2 concentrations in 29 patients with anorexia nervosa (AN) before and after refeeding and compares it to physiological adaptations during fasting in healthy controls or to mouse model of chronic food restriction and refeeding. Acute and chronic food restriction decrease LEAP-2 and increase ghrelin concentrations in both humans and mice, while patients with AN displayed higher ghrelin and LEAP-2 concentrations before than after refeeding (p = 0.043). After 6 months follow-up, patients with unstable weight gain (n = 17) had significantly decreased LEAP-2 concentrations after refeeding (p = 0.044), in contrast to patients with stable weight gain (n = 12). We provide evidence that the ghrelin/LEAP-2 system is not regulated according to the nutritional status in AN, in contrast to what is physiologically expected when coping with food restriction.
Fichier principal
Vignette du fichier
Tezenas et al. 2023 IScience-LEAP.pdf (6.12 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04386915 , version 1 (11-01-2024)




Chloé Tezenas Du Montcel, Philibert Duriez, Jingxian Cao, Nicolas Lebrun, Nicolas Ramoz, et al.. The role of dysregulated ghrelin/LEAP-2 balance in anorexia nervosa.. iScience, 2023, iScience, 26 (11), pp.107996. ⟨10.1016/j.isci.2023.107996⟩. ⟨hal-04386915⟩
16 Consultations
5 Téléchargements



Gmail Mastodon Facebook X LinkedIn More